CAREVIEW COMMUNICATIONS, INC. 8-K


EXHIBIT 10.45


 





Execution
Version







 





SIXTH AMENDMENT TO CREDIT AGREEMENT 


 


SIXTH AMENDMENT TO
CREDIT AGREEMENT (this “Amendment”), dated as of February 6, 2020, by and among CAREVIEW COMMUNICATIONS,
INC., a Nevada corporation (“Holdings”), CAREVIEW COMMUNICATIONS, INC., a Texas corporation and a wholly-owned
subsidiary of Holdings (the “Borrower”), PDL INVESTMENT HOLDINGS, LLC (as assignee of PDL BioPharma,
Inc.), a Delaware limited liability company (both in its capacity as the lender (the “Initial Lender”)
and in its capacity as Agent (solely in such capacity as Agent, the “Agent”)) under the Credit Agreement
(as defined below) and Steven G. Johnson and Dr. James R. Higgins (each, an individual), as lender (collectively, the “Tranche
Three Lender” and, together with the Initial Lender, the “Lenders”).


 


W I T N E S S E T H


 


WHEREAS Holdings, the
Borrower, the Initial Lender and the Agent have entered into that certain Credit Agreement dated as of June 26, 2015 (as amended
by this Amendment and as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Credit
Agreement”); and


 


WHEREAS, the Borrower
the Agent and the Lenders wish to amend the Credit Agreement as set forth herein.


 


Article
I.

DEFINITIONS


 


1.1          Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this Amendment,
including its preamble and recitals, have the meanings provided in the Credit Agreement.


 


Article
II.

AMENDMENTS


 


2.1          Amendments to Credit Agreement. Upon satisfaction of the conditions set forth in Section 2.2 hereof, the Credit
Agreement shall be amended to delete the stricken text (indicated textually in the same manner as the following example: stricken
text) and to add the double-underlined text (indicated textually in the same manner as the following example:
double-underlined text) as follows:


 


(a)           Amendments to Section 1.1:


 


“Additional
Tranche Three Funding Date” means the date on which the conditions set forth in Section 4.4 have been satisfied or waived
by the Agent in its sole discretion and the additional Tranche Three Loan is funded, which date shall occur no later than February
6, 2020.


 


“Additional
Tranche Three Loan” means the term loan from the Tranche Three Lender on the Additional Tranche Three Funding Date pursuant
to Section 2.1.1(c).


 






     


     


    

 


“HealthCor
Note and Warrant Purchase Agreement” means the Note and Warrant Purchase Agreement dated as of April 21, 2011, among Holdings,
HealthCor Partners Fund, L.P., HealthCor Hybrid Offshore Master Fund, L.P., and the other investors party thereto, as amended pursuant
to the First Amendment dated December 30, 2011, the Second Amendment dated January 31, 2012, the Third Amendment dated August 20,
2013, the Fourth Amendment dated January 16, 2014, the Fifth Amendment dated December 15, 2014, the Sixth Amendment dated March
31, 2015, the Seventh Amendment dated as of June 26, 2015, the Eighth Amendment dated as of February 23, 2018, the Ninth Amendment
dated as of July 10, 2018, and as further amended, restated, supplemented or otherwise modified pursuant to (i) the Tenth Amendment
to Note and Warrant Purchase Agreement dated as of July 13, 2018, (ii) the Eleventh Amendment to Note and Warrant Purchase Agreement
dated as of March 27, 2019, (iii) the Twelfth Amendment to Note and Warrant Purchase Agreement dated as of May 15, 2019, and
(iv) the
Thirteenth Amendment to Note and Warrant Purchase Agreement dated as of February 6, 2020, and
(v) the terms of the Intercreditor Agreement, as
amended.


 


“Initial
Tranche Three Funding Date” means May 15, 2019, the date on which the initial Tranche Three Loan was funded.


 


“Initial
Tranche Three Loan” means the term loan from the Tranche Three Lender on the Initial Tranche Three Funding Date pursuant
to Section 2.1.1(c).


 


“Sixth
Amendment” means that certain Sixth Amendment to Credit Agreement dated as of February 6, 2020 by and among Holdings, the
Borrower, the Lender, the Tranche Three Lender and the Agent.


 


“Tranche
Three Commitment” means, as to the Tranche Three Lender, the Tranche Three Lender’s commitment to provide the Tranche
Three Loan in the aggregate principal amount of $700,000, (i) $200,000
on the Initial Tranche Three Funding Date and (ii) $500,000
on the Additional Tranche Three Funding Date, pursuant to Section 2.1.1(c).


 


“Tranche Three Funding
Date” means the date on which the conditions set forth in Section 4.4 have been satisfied or waived by the
Agent in its sole discretion and the Tranche Three Loan is funded, which date shall occur no later than May 15,
2019.


 


“Tranche
Three Loan” means, collectively, the
term loan loans
from the Tranche Three Lender pursuant to Section 2.1.1(c).


 


(b)           Amendments to Section 2.1.1(c):


 


(c)(i)
on the Initial Tranche Three Funding Date, the
entire amount of its Tranche Three Commitment $200,000
and (ii) on the Additional Tranche Three Funding Date, $500,000, after which the Tranche Three Commitment shall
terminate in full.


 






    2 


     


    

 


(c)           Amendments to Section 2.3.1(c):


 


(c) The Borrower
promises to pay interest on the unpaid principal amount of (i) the
Initial Tranche Three Loan for the period commencing
on the Initial Tranche Three Funding Date until such Tranche Three Loan is Paid in Full
and (ii) the Additional Tranche Three Loan for the period
commencing on the Additional Tranche Three Funding Date until such Tranche Three Loan is Paid in Full, in each case
at a rate payable in cash per annum equal to 15.5%.


 


(d)           Amendments to Section 2.3.2(c):


 


(c) Subject to
Section 2.7, interest accrued on the Tranche Three Loan during the period from the Initial
Tranche Three Funding Date or the Additional Tranche Three Funding
Date, as applicable, until the Tranche Three Maturity Date shall accrue and be payable in cash (subject to Section
2.7) quarterly on each Interest Payment Date, in arrears, and, to the extent not paid in advance, upon a prepayment of the
Tranche Three Loan in accordance with Section 2.4 and on the Tranche Three Maturity Date, in each such case, in cash. Subject
to Section 2.7, after the Tranche Three Maturity Date and at any time an Event of Default exists, all accrued interest on
the Tranche Three Loan shall be payable in cash on demand at the rates specified in Section 2.3.1.


 


(e)           Amendments to Section 7.1(f):


 


(f) HealthCor
Obligations in an aggregate principal amount not to exceed the aggregate principal amount of the HealthCor Notes outstanding as
of May 15, 2019 February
6, 2020, plus accrued interest thereon that is paid-in-kind and added to the principal balance thereof in accordance
with the terms of the HealthCor Debt Documents, and any Permitted Refinancing thereof so long as concurrently with the closing
of any such Permitted Refinancing the lenders or investors (or any agent with the power to enter into a binding obligation on behalf
of such lenders or investors) in respect of such Permitted Refinancing enter into an intercreditor agreement satisfactory in form
and substance to the Agent;


 


2.2         Conditions to Effectiveness. This Amendment shall become effective on the date that each of the following
conditions are satisfied (the “Amendment Effective Date”):


 


(a)           receipt by the Agent of counterparts of this Amendment which shall be collectively executed by each of the Borrower,
the Lenders and the Agent;


 


(b)           the Borrower shall have received the proceeds from the sale of additional notes under the HealthCor Note and Warrant
Purchase Agreement in an aggregate amount of not less than $100,000;


 






    3 


     


    

 


(c)           receipt by the Agent of a fully executed Nineteenth Amendment to the Modification Agreement in form and substance
satisfactory to the Agent; and


 


(d)           the Borrower shall have paid to the Agent all costs and expenses of the Agent and the Lenders (including the fees,
costs and expenses of legal counsel incurred in connection with the transactions contemplated under this Amendment) incurred in
connection with the transactions contemplated by this Amendment.


 


Article
III.

MISCELLANEOUS


 


3.1           Loan Document. This Amendment is a Loan Document executed pursuant to the Credit Agreement and shall (unless
otherwise expressly indicated therein) be construed, administered and applied in accordance with the terms and provisions of the
Credit Agreement.


 


3.2           Effect of Amendment. Except as expressly set forth herein, this Amendment shall not by implication or otherwise
limit, impair, constitute a waiver of, or otherwise affect, the rights and remedies of the parties to the Credit Agreement and
shall not alter, modify, amend or in any way affect any of the terms or conditions contained therein, all of which are ratified
and affirmed in all respects and shall continue in full force and effect. Nothing herein shall be deemed to entitle the Borrower
to any future consent, to, or waiver, amendment, modification or other change of, any of the terms or conditions contained in the
Credit Agreement in similar or different circumstances. Except as expressly stated herein, the Agent and the Lenders reserve all
rights, privileges and remedies under the Loan Documents. All references in the Credit Agreement and the other Loan Documents to
the Credit Agreement shall be deemed to be references to the Credit Agreement as modified hereby.


 


3.3           Reaffirmation. The Borrower hereby reaffirms the Obligations under each Loan Document to which it is a party.
The Borrower hereby further ratifies and reaffirms the validity and enforceability of all of the liens and security interests heretofore
granted, pursuant to and in connection with the Security Agreement or any other Loan Document, to the Agent, as collateral security
for the Obligations under the Loan Documents in accordance with their respective terms, and acknowledges that all of such Liens
and security interests, and all Collateral heretofore pledged as security for such obligations, continue to be and remain collateral
for such Obligations from and after the date hereof.


 


3.4           Counterparts. This Amendment may be executed by the parties hereto in several counterparts, each of which
shall be deemed to be an original and all of which shall constitute together but one and the same agreement. Delivery of an executed
signature page of this Amendment by facsimile transmission or electronic transmission shall be as effective as delivery of a manually
executed counterpart hereof.


 


3.5           Construction; Captions. Each party hereto hereby acknowledges that all parties hereto participated equally
in the negotiation and drafting of this Amendment and that, accordingly, no court construing this Amendment shall construe it more
stringently against one party than against the other. The captions and headings of this Amendment are for convenience of reference
only and shall not affect the interpretation of this Amendment.


 






    4 


     


    

 


3.6           Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the parties hereto
and their respective successors and assigns (as permitted under the Credit Agreement).


 


3.7           Governing Law. This Amendment SHALL BE A CONTRACT MADE UNDER AND GOVERNED
BY THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT
REGARD TO CONFLICT OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW).


 


3.8           Severability. The illegality or unenforceability of any provision of this Amendment or any instrument or agreement
required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Amendment
or any instrument or agreement required hereunder.


 


3.9           Release of Claims. In consideration of the Lenders’ and Agent’s agreements contained in this Amendment,
the Borrower hereby releases and discharges each Lender and the Agent and their affiliates, subsidiaries, successors, assigns,
directors, officers, employees, agents, consultants and attorneys (each, a “Released Person”) of and
from any and all other claims, suits, actions, investigations, proceedings or demands, whether based in contract, tort, implied
or express warranty, strict liability, criminal or civil statute or common law of any kind or character, known or unknown, which
Borrower ever had or now has against the Agent, any Lender or any other Released Person which relates, directly or indirectly,
to any acts or omissions of the Agent, any Lender or any other Released Person relating to the Credit Agreement or any other Loan
Document on or prior to the date hereof; provided however, that this release shall not apply to future claims or causes of action
by the Borrower.


 


3.10        
Tranche Three Lender. The Tranche Three Lender and the Administrative Agent, for the benefit of the Secured
Parties, hereby agree as follows: The Tranche Three Lender (x) represents and warrants that (i) it has full power and authority,
and has taken all action necessary, to execute and deliver this Amendment and to consummate the transactions contemplated hereby,
(ii) it has received copies of the Credit Agreement and such other documents and information as it deems appropriate to make its
own credit analysis and decision to enter into this Amendment and make the Additional Tranche Three Loan, and (iii) it has, independently
and without reliance upon the Agent or the Initial Lender and based on such documents and information as it has deemed appropriate,
made its own credit analysis and decision to enter into this Amendment and make the Additional Tranche Three Loan, and (y) agrees
that (i) it will, independently and without reliance on the Agent or the Initial Lender, and based on such documents and information
as it shall deem appropriate at the time, continue to make its own credit analysis and decisions in taking or not taking action
under the Loan Documents, and (ii) it will perform in accordance with their terms all of the obligations which by the terms of
the Loan Documents are required to be performed by it as the Tranche Three Lender.


 


[Signature page follows]


 




    5 


     


    

 


Each of the parties
hereto has caused a counterpart of this Amendment to be duly executed and delivered as of the date first above written.


 





	 	CAREVIEW COMMUNICATIONS, INC., 

a Nevada corporation, 

as Holdings
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	Name: Steven G. Johnson
	 	Title: President and Chief Executive Officer
	 	 	 
	 	CAREVIEW COMMUNICATIONS, INC., 

a Texas corporation, 

as Borrower
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	Name: Steven G. Johnson
	 	Title: President and Chief Executive Officer
	 	 	 
	 	PDL INVESTMENT HOLDINGS, LLC,

 a Delaware limited liability company, 

as Agent
	 	 	 
	 	By:	/s/ Christopher Stone
	 	Name: Christopher Stone
	 	Title: CEO and Treasurer
	 	 	 
	 	PDL INVESTMENT HOLDINGS, LLC, 

a
    Delaware limited liability company, 

as the Lender
	 	 	 
	 	By:	/s/ Christopher Stone
	 	Name: Christopher Stone
	 	Title: CEO and Treasurer
	 	 	 
	 	TRANCHE THREE LENDER:
	 	 	 
	 	/s/ Steven G. Johnson
	 	Steven G. Johnson (individually)
	 	 	 
	 	/s/ Dr. James R. Higgins
	 	Dr. James R. Higgins
    (individually)




  


Sixth Amendment to Credit Agreement